Dublin, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The "Portugal Real-Time PCR And Digital PCR Market | Industry, Segmentation, Share, Trends, Value, Growth, Size & Revenue : Market Forecast By Technology, By Application, By End User and Competitive lanscape" report has been added to ResearchAndMarkets.com's offering.
The Portuguese Real-Time PCR And Digital PCR Market has experienced significant expansion in recent years, driven by growing investments in healthcare, biotechnology, and pharmaceuticals, Portugal has made remarkable strides in enhancing its diagnostic and public health capabilities. Between 2018 and 2022, the country's healthcare sector witnessed significant funding increases, resulting in tangible improvements, such as a rise in the number of hospitals from 230 to 243. This growth reflects Portugal's commitment to strengthening its healthcare infrastructure and ensuring better access to advanced medical technologies for its population.
Portugal's Real-Time PCR And Digital PCR Market size is projected to grow at a CAGR of 4.1% during 2024-2030F. driven by advancements in healthcare infrastructure, biotechnology, and diagnostic research. Investments in these sectors have fueled the adoption of cutting-edge PCR technologies, catering to both clinical diagnostics and research applications.
Such as, Portugal's healthcare sector has seen consistent funding growth, with initiatives aimed at modernizing diagnostic capabilities and expanding access to advanced medical tools. Additionally, collaborations between public institutions and private companies have accelerated research efforts, particularly in infectious disease diagnostics and genomic studies, further driving market demand.
Quantitative PCR command a significant portion of the revenue as compared to Digital PCR due to their crucial role in diagnostics and research across healthcare, biotechnology. Additionally, in terms of end-users, hospitals and diagnostic centers have claimed the largest portion, his dominance is primarily attributed to the extensive utilization of Quantitative PCR in these facilities for clinical diagnostics, including infectious diseases, oncology, and genetic testing. Its reliability, speed, and accuracy make it a cornerstone in routine diagnostic workflows, enabling hospitals and diagnostic centers to deliver precise and timely results for patient care.
Market Segmentation
By Technology
During the forecast period, Digital PCR are projected to lead the Portugal Real-Time PCR And Digital PCR Market owing to dPCR offers unparalleled sensitivity and quantification capabilities compared to traditional Quantitative PCR (qPCR). This makes it ideal for detecting rare mutations, minimal residual disease in cancer patients, and low-level viral loads.
By Application
During the forecast period, oncology testing are projected to lead the Portugal Real-Time PCR And Digital PCR Market owing to The increasing prevalence of cancer in Portugal, creating an urgent need for advanced diagnostic tools like real-time and digital PCR for early detection, monitoring, and personalized treatment planning.
By End User
By End User, Pharma and biotech companies are expected to witness the highest growth in in future driven by increasing investments in personalized medicine, biologics, and infectious disease diagnostics. For instance, companies like Bial and startups such as LiMM Therapeutics are leveraging PCR technologies for drug development and genomics research, while international collaborations further boost R&D initiatives.
Key Topics Covered:
1. Executive Summary
2. Introduction
3. Portugal Real-Time PCR And Digital PCR Market Overview
3.1 Portugal Real-Time PCR And Digital PCR Market Revenues (2020-2030F)
3.2 Portugal Real-Time PCR And Digital PCR Market Industry Life Cycle
3.3 Portugal Real-Time PCR And Digital PCR Market Porter Five Forces
4. Portugal Real-Time PCR And Digital PCR Market Dynamics
4.1 Impact Analysis
4.2 Market Drivers
4.3 Market Restraint
5. Portugal Real-Time PCR And Digital PCR Market Trends & Evolution
6. Portugal Real-Time PCR And Digital PCR Market Overview, By Technology
6.1 Portugal Real-Time PCR And Digital PCR Market Revenue Share and Revenues, By Technology
6.1.1 Portugal Real-Time PCR And Digital PCR Market Revenues, By Quantitative PCR
6.1.2 Portugal Real-Time PCR And Digital PCR Market Revenues, By Digital PCR
7. Portugal Real-Time PCR And Digital PCR Market Overview, By Application
7.1 Portugal Real-Time PCR And Digital PCR Market Revenue Share and Revenues, Application
7.1.1 Portugal Real-Time PCR And Digital PCR Market Revenues, By Clinical Applications
7.1.2 Portugal Real-Time PCR And Digital PCR Market Revenues, By Research Application
7.1.3 Portugal Real-Time PCR And Digital PCR Market Revenues, By Pathogen Testing
7.1.4 Portugal Real-Time PCR And Digital PCR Market Revenues, By Oncology Testing
7.1.5 Portugal Real-Time PCR And Digital PCR Market Revenues, By Blood Screening
7.1.6 Portugal Real-Time PCR And Digital PCR Market Revenues, By Others
8. Portugal Real-Time PCR And Digital PCR Market Overview, By End-User
8.1 Portugal Real-Time PCR And Digital PCR Market Revenue Share and Revenues, End-User
8.1.1 Portugal Real-Time PCR And Digital PCR Market Revenues, By Hospitals & Diagnostic Centers
8.1.2 Portugal Real-Time PCR And Digital PCR Market Revenues, By Research Laboratories & Academic Institutes
8.1.3 Portugal Real-Time PCR And Digital PCR Market Revenues, By Pharmaceutical & Biotechnology Companies
8.1.4 Portugal Real-Time PCR And Digital PCR Market Revenues, By Clinical Research Organizations
8.1.5 Portugal Real-Time PCR And Digital PCR Market Revenues, By Forensic Laboratories
9. Portugal Real-Time PCR And Digital PCR Market Key Performance Indicators
10. Portugal Real-Time PCR And Digital PCR Market Opportunity Assessment
10.1 Portugal Real-Time PCR And Digital PCR Market Opportunity Assessment, By Technology
10.2 Portugal Real-Time PCR And Digital PCR Market Opportunity Assessment, By Application
10.3 Portugal Real-Time PCR And Digital PCR Market Opportunity Assessment, By End User
11. Portugal Real-Time PCR And Digital PCR Market Competitive Benchmarking
11.1 Portugal Real-Time PCR And Digital PCR Market Revenue Ranking (2023), By Top 3 Companies
11.2 Portugal Real-Time PCR And Digital PCR Market Competitive Benchmarking, By Operating Parameters
12. Company Profiles
- Fisher Scientific
- QIAGEN
- NZYtech
- BIOPORTUGAL
- Biomerieux
- Altona Diagnostics
- Vitro Master Diagnostica
- Roche
- Bio-Rad laboratories
For more information about this report visit https://www.researchandmarkets.com/r/j07wvg
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
